Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589
机构：[1]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Hebei University of Traditional Chinese Medicine, No.326, Xinshi South Road, Qiaoxi District, Shijiazhuang 05000, China.[2]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Acupuncture and moxibustion and Massage College of Hebei University of Chinese Medicine, No.3 Xingyuan Road, Luquan District, Shijiazhuang 050200, China.[3]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China.[4]The Third Hospital of Hebei Medical University, Shijiazhuang 050200, China.[5]Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang 050200, China.[6]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Hebei University of Traditional Chinese Medicine, No.326, Xinshi South Road, Qiaoxi District, Shijiazhuang 05000, China. Electronic address: yangfan001@hebcm.edu.cn.[7]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Hebei University of Traditional Chinese Medicine, No.326, Xinshi South Road, Qiaoxi District, Shijiazhuang 05000, China; The Second Affiliated Hospital of Hebei University of Traditional Chinese Medicine, Dingzhou 073000, China. Electronic address: wangyuehua@hebcm.edu.cn.
第一作者机构：[1]Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Hebei University of Traditional Chinese Medicine, No.326, Xinshi South Road, Qiaoxi District, Shijiazhuang 05000, China.
推荐引用方式(GB/T 7714)：
Huang Jiaan,Liu Yan,Shi Mengting,et al.Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589[J].BIOMEDICINE & PHARMACOTHERAPY.2025,189:118321.doi:10.1016/j.biopha.2025.118321.
APA：
Huang Jiaan,Liu Yan,Shi Mengting,Zhang Xiaoyun,Zhong Yan...&Wang Yuehua.(2025).Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589.BIOMEDICINE & PHARMACOTHERAPY,189,
MLA：
Huang Jiaan,et al."Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589".BIOMEDICINE & PHARMACOTHERAPY 189.(2025):118321
